Pika T - Search Results

1

[Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Petrová P, Minarík J, Pika T, Bacovský J, Adamová D, Langová K; Ceská myelomová skupina. Scudla V, et al. Among authors: pika t. Klin Onkol. 2010;23(3):171-81. Klin Onkol. 2010. PMID: 20608327 Czech.

2

[Comparison of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Pika T, Minarík J, Zemanová M, Bacovský J, Heincová V; Ceská myelomová skupina. Scudla V, et al. Among authors: pika t. Vnitr Lek. 2006 Mar;52(3):232-40. Vnitr Lek. 2006. PMID: 16722154 Czech.

3

[Contribution to the evaluation of the relationship between angiogenic cytokines, selected biological parameters and prognostic factors in multiple myeloma].

Scudla V, Pika T, Budíková M, Ordeltová M, Minarík J, Zemanová M, Bacovský J, Srovnalík K; Ceská myelomová skupina. Scudla V, et al. Among authors: pika t. Cas Lek Cesk. 2006;145(12):929-35. Cas Lek Cesk. 2006. PMID: 17323615 Czech.

4

[Assessment of plasmatic cell proliferation and apoptosis indexes in the course of multiple myeloma].

Minarík J, Scudla V, Ordeltová M, Bacovský J, Zemanová M, Pika T. Minarík J, et al. Among authors: pika t. Vnitr Lek. 2008 Jan;54(1):31-5. Vnitr Lek. 2008. PMID: 18390115 Czech.

5

Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma.

Zemanova M, Scudla V, Adam Z, Gregora E, Pour L, Minarik J, Pavlicek P, Pika T, Bacovsky J. Zemanova M, et al. Among authors: pika t. Neoplasma. 2008;55(4):345-9. Neoplasma. 2008. PMID: 18505347 Clinical Trial.

6

The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma.

Pika T, Minarik J, Schneiderka P, Budikova M, Langova K, Lochman P, Bacovsky J, Farbiakova V, Scudla V. Pika T, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):61-4. doi: 10.5507/bp.2008.009. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008. PMID: 18795076

7

Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib.

Minarik J, Scudla V, Ordeltova M, Bacovsky J, Pika T, Langova K. Minarik J, et al. Among authors: pika t. Eur J Haematol. 2009 Dec 1;83(6):528-34. doi: 10.1111/j.1600-0609.2009.01321.x. Epub 2009 Jul 18. Eur J Haematol. 2009. PMID: 19624720

8

[The comparison of serum levels of selected biomarkers in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Pika T, Bacovský J, Minarík J, Heinzová V, Langová K. Scudla V, et al. Among authors: pika t. Cas Lek Cesk. 2009;148(7):315-22. Cas Lek Cesk. 2009. PMID: 19642297 Czech.

9

Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myeloma.

Minarik J, Scudla V, Ordeltova M, Bacovsky J, Pika T, Langova K. Minarik J, et al. Among authors: pika t. Leuk Lymphoma. 2009 Dec;50(12):1983-91. doi: 10.3109/10428190903291070. Leuk Lymphoma. 2009. PMID: 19860618

10

Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma.

Minarik J, Scudla V, Bacovsky J, Zemanova M, Pika T, Ordeltova M, Langova K. Minarik J, et al. Among authors: pika t. Neoplasma. 2010;57(1):8-14. doi: 10.4149/neo_2010_01_008. Neoplasma. 2010. PMID: 19895166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters